You are here

Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Ovulation
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0-36
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy women of legal age of consent who are willing to use a combination OC.

- Subjects must be under the age of 36 at the time of enrollment (visit 3).

- Subjects must have had regular (24 to 32 day) menstrual cycles for the 3-month period
preceding entry into the pretreatment observation cycle, excluding postabortal and
nonnursing postpartum subjects. Postabortal and nonnursing postpartum subjects must
have completed at least 1 regular (24 to 32 day) spontaneous menstrual cycle before
entry into the pretreatment observation cycle. The pretreatment observation cycle for
all subjects will begin on day 1 of the subsequent spontaneous menses.

Other inclusions apply.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

A history or the presence of any of the following will prevent enrollment:

- Thrombophlebitis, thrombosis, or thromboembolic disorders.

- Deep vein thrombosis.

- Pulmonary embolism.

Other exclusions apply.

NCT00254189
Pfizer
Completed
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now